← Open Payments lookup

MARYLIE BUCKOSKI: Open Payments

NPI 1649756586 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,190 in 59 payments from 15 companies in 2025. Trend: 2023 $480 · 2024 $1,399 · 2025 $1,190

Food & beverage: $1,190
CompanyPaymentsAmount
GlaxoSmithKline, LLC.17$343
AstraZeneca Pharmaceuticals LP11$227
Boehringer Ingelheim Pharmaceuticals, Inc.7$150
Insmed, Inc.5$105
Verona Pharma, Inc.4$83
Electromed, Inc.5$61
GENZYME CORPORATION2$51
Regeneron Healthcare Solutions, Inc.1$37
United Therapeutics Corporation1$27
Philips North America LLC1$23

Products named: NUCALA, FASENRA, Arikayce, DUPIXENT, Ohtuvayre, TRELEGY ELLIPTA, SMARTVEST, TEZSPIRE.

Industry payments across TX — which companies pay providers there.